RankAlpha logo
Back to Rankings

NBTX

NanobiotixF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
NBTX vs peer average
15/100
NBTX vs. peer average (F vs. C)
Grade spread
A 1 · B 4 · C 2 · D 1 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

NVS is the first available peer comparator.

Major global pharma with oncology franchises — useful for framing potential commercial execution scenarios.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerNVSNovartis
NBTX
Nanobiotix
NVS
Novartis
Grade
F
B
Momentum
65
32
Value
46
64
Sentiment
13
70
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs NVS

NBTX / NVS
Grade Position
Below peers
NBTX vs. peer average (F vs. C)
15/100
Momentum
65
NBTX
Value
46
NVS
Sentiment
13
NVS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs NBTX
1
NVS
NVS
B
80/100
-3
2
STOK
Stoke Therapeutics Inc Common
B
80/100
-3
3
ADMA
ADMA Biologics Inc Common
A
100/100
-4
4
SEPN
Septerna Inc Common
C
60/100
-2
5
GHRS
GH Research Plc Common
D
40/100
-1
NVS is the first peer returned for this comparison set.